VivoSeq
Other

Post Operative Pain

22

Pipeline Programs

78

Active Trials

26

Companies Involved

Post Operative Pain is an emerging landscape with 22 programs across 26 companies. The most active players are Pacira Pharmaceuticals, Inc, TLC Biopharmaceuticals, Inc., Shanghai Huilun Pharmaceutical Co., Ltd.. 5 therapies are approved with 3 more in late-stage development.

Pipeline Metrics

Competitive Density

62/100

Pipeline Velocity

66/100

Mech. Concentration

38/100

Completion Rate

89/100

Attrition Rate

7/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

Trial Status

398

clinical trials

Completed216 · 54%
Unknown status77 · 19%
Recruiting50 · 13%
Not yet recruiting20 · 5%
Terminated16 · 4%
Withdrawn10 · 3%
Other9 · 2%

Trial Activity

398 trials

Dextromethorphan for Treatment of Postoperative Pain
Recruiting··N/A·NCT05278494·160 enrolled
Intrapleural Nebulization of Bupivacain to Reduce Postoperative Pain
Recruiting··N/A·NCT05282251·60 enrolled
Melatonin on Post Operative Pain After CS
Recruiting··N/A·NCT07380568·60 enrolled
Page 1 of 27

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)